期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 61, 期 2, 页码 -出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01590-16
关键词
bisphosphonates; Cryptosporidium parvum; farnesyl diphosphate synthase; isoprenoids; Plasmodium falciparum; Toxoplasma gondii
资金
- National Research Council of Argentina [PIP 0797]
- ANPCyT (PICT) [0457]
- Universidad de Buenos Aires [20020130100223BA]
- U.S. National Institutes of Health [AI-102254]
We tested a series of sulfur-containing linear bisphosphonates against Toxoplasma gondii, the etiologic agent of toxoplasmosis. The most potent compound (compound 22; 1-[(n-decylsulfonyl) ethyl]-1,1-bisphosphonic acid) is a sulfone-containing compound, which had a 50% effective concentration (EC50) of 0.11 +/- 0.02 mu M against intracellular tachyzoites. The compound showed low toxicity when tested in tissue culture with a selectivity index of >2,000. Compound 22 also showed high activity in vivo in a toxoplasmosis mouse model. The compound inhibited the Toxoplasma farnesyl diphosphate synthase (TgFPPS), but the concentration needed to inhibit 50% of the enzymatic activity (IC50) was higher than the concentration that inhibited 50% of growth. We tested compound 22 against two other apicomplexan parasites, Plasmodium falciparum (EC50 of 0.6 +/- 0.01 mu M), the agent of malaria, and Cryptosporidium parvum (EC50 of similar to 65 mu M), the agent of cryptosporidiosis. Our results suggest that compound 22 is an excellent novel compound that could lead to the development of potent agents against apicomplexan parasites.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据